 Kia Washington
Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eye | 4 | 2016 | 101 | 2.070 |
Why?
| | Facial Transplantation | 4 | 2022 | 9 | 1.640 |
Why?
| | Blindness | 3 | 2016 | 37 | 1.610 |
Why?
| | Tacrolimus | 5 | 2024 | 143 | 1.460 |
Why?
| | Vascularized Composite Allotransplantation | 3 | 2023 | 22 | 1.310 |
Why?
| | Vibrissae | 3 | 2022 | 11 | 1.080 |
Why?
| | Myelin Sheath | 2 | 2024 | 145 | 0.850 |
Why?
| | Nerve Regeneration | 6 | 2024 | 53 | 0.780 |
Why?
| | Optic Nerve Injuries | 2 | 2017 | 4 | 0.720 |
Why?
| | Tissue and Organ Harvesting | 2 | 2016 | 69 | 0.680 |
Why?
| | Rats | 14 | 2024 | 5034 | 0.620 |
Why?
| | Organ Transplantation | 2 | 2016 | 161 | 0.560 |
Why?
| | Peripheral Nerve Injuries | 2 | 2018 | 32 | 0.560 |
Why?
| | Somatosensory Cortex | 2 | 2022 | 34 | 0.530 |
Why?
| | Transplantation, Homologous | 6 | 2020 | 397 | 0.530 |
Why?
| | Neurons, Afferent | 1 | 2016 | 88 | 0.510 |
Why?
| | Retina | 1 | 2016 | 267 | 0.480 |
Why?
| | Composite Tissue Allografts | 2 | 2022 | 8 | 0.420 |
Why?
| | Adaptation, Physiological | 1 | 2016 | 476 | 0.410 |
Why?
| | Graft Rejection | 5 | 2022 | 533 | 0.390 |
Why?
| | Surgery, Plastic | 2 | 2020 | 25 | 0.340 |
Why?
| | Hindlimb | 5 | 2023 | 125 | 0.340 |
Why?
| | Tissue Transplantation | 1 | 2009 | 11 | 0.330 |
Why?
| | Craniofacial Abnormalities | 1 | 2009 | 59 | 0.320 |
Why?
| | Animals | 18 | 2024 | 32102 | 0.310 |
Why?
| | Neurons | 3 | 2024 | 1298 | 0.280 |
Why?
| | Urethane | 1 | 2024 | 41 | 0.230 |
Why?
| | Carbamates | 1 | 2024 | 35 | 0.230 |
Why?
| | Urea | 1 | 2024 | 69 | 0.220 |
Why?
| | Esters | 1 | 2024 | 61 | 0.220 |
Why?
| | Facial Hemiatrophy | 1 | 2023 | 1 | 0.220 |
Why?
| | Costal Cartilage | 1 | 2023 | 2 | 0.220 |
Why?
| | Amides | 1 | 2024 | 88 | 0.220 |
Why?
| | Tissue Scaffolds | 2 | 2023 | 180 | 0.220 |
Why?
| | Physical Stimulation | 1 | 2022 | 78 | 0.210 |
Why?
| | Free Tissue Flaps | 1 | 2023 | 32 | 0.210 |
Why?
| | Thalamus | 1 | 2022 | 78 | 0.200 |
Why?
| | Visual Pathways | 1 | 2022 | 44 | 0.200 |
Why?
| | Immunosuppressive Agents | 5 | 2023 | 666 | 0.200 |
Why?
| | Skin Transplantation | 2 | 2014 | 58 | 0.200 |
Why?
| | Manganese | 1 | 2022 | 55 | 0.200 |
Why?
| | Rats, Inbred Lew | 6 | 2023 | 93 | 0.200 |
Why?
| | Surgical Flaps | 2 | 2014 | 121 | 0.180 |
Why?
| | Rectus Abdominis | 1 | 2020 | 9 | 0.180 |
Why?
| | Rats, Inbred BN | 5 | 2023 | 53 | 0.180 |
Why?
| | Glial Cell Line-Derived Neurotrophic Factor | 1 | 2020 | 16 | 0.180 |
Why?
| | Parental Leave | 1 | 2019 | 17 | 0.170 |
Why?
| | Sexism | 1 | 2020 | 43 | 0.170 |
Why?
| | Physicians, Women | 1 | 2019 | 55 | 0.160 |
Why?
| | Family Planning Services | 1 | 2019 | 67 | 0.160 |
Why?
| | Peripheral Nerves | 1 | 2018 | 65 | 0.150 |
Why?
| | Career Choice | 1 | 2019 | 183 | 0.150 |
Why?
| | Recovery of Function | 2 | 2013 | 577 | 0.150 |
Why?
| | Tissue Survival | 1 | 2016 | 13 | 0.140 |
Why?
| | Retinal Ganglion Cells | 1 | 2017 | 92 | 0.140 |
Why?
| | Leadership | 1 | 2020 | 302 | 0.140 |
Why?
| | Hydrogels | 1 | 2023 | 581 | 0.140 |
Why?
| | Refractory Period, Electrophysiological | 1 | 2016 | 5 | 0.130 |
Why?
| | Trigeminal Ganglion | 1 | 2016 | 21 | 0.130 |
Why?
| | Surgeons | 1 | 2020 | 238 | 0.130 |
Why?
| | Graft Survival | 3 | 2023 | 480 | 0.130 |
Why?
| | Evoked Potentials, Somatosensory | 1 | 2016 | 31 | 0.130 |
Why?
| | Beneficence | 1 | 2016 | 18 | 0.130 |
Why?
| | Central Nervous System | 1 | 2017 | 239 | 0.130 |
Why?
| | Education, Medical, Graduate | 1 | 2019 | 376 | 0.130 |
Why?
| | Lymphoproliferative Disorders | 1 | 2016 | 46 | 0.130 |
Why?
| | Social Justice | 1 | 2016 | 66 | 0.130 |
Why?
| | Cervicoplasty | 1 | 2014 | 1 | 0.120 |
Why?
| | Postoperative Care | 1 | 2016 | 222 | 0.120 |
Why?
| | Neck Injuries | 1 | 2014 | 18 | 0.120 |
Why?
| | Extracellular Matrix | 1 | 2018 | 439 | 0.120 |
Why?
| | Reaction Time | 1 | 2016 | 373 | 0.120 |
Why?
| | Feasibility Studies | 1 | 2016 | 741 | 0.110 |
Why?
| | Swine | 3 | 2022 | 704 | 0.110 |
Why?
| | Tissue and Organ Procurement | 1 | 2016 | 243 | 0.110 |
Why?
| | Patient Selection | 1 | 2016 | 654 | 0.110 |
Why?
| | Transplantation, Isogeneic | 2 | 2009 | 17 | 0.110 |
Why?
| | Allografts | 2 | 2023 | 127 | 0.100 |
Why?
| | Swine, Miniature | 2 | 2022 | 71 | 0.100 |
Why?
| | Burns | 1 | 2014 | 242 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 1 | 2016 | 2262 | 0.090 |
Why?
| | Immune Tolerance | 2 | 2009 | 332 | 0.090 |
Why?
| | Cyclosporine | 4 | 2013 | 169 | 0.090 |
Why?
| | Facial Asymmetry | 1 | 2009 | 5 | 0.080 |
Why?
| | Mandibulofacial Dysostosis | 1 | 2009 | 5 | 0.080 |
Why?
| | Humans | 10 | 2023 | 115587 | 0.080 |
Why?
| | Disease Models, Animal | 2 | 2016 | 3580 | 0.080 |
Why?
| | Cleft Lip | 1 | 2009 | 31 | 0.080 |
Why?
| | Craniosynostoses | 1 | 2009 | 28 | 0.080 |
Why?
| | Nose | 1 | 2009 | 56 | 0.080 |
Why?
| | Age Factors | 1 | 2016 | 2907 | 0.080 |
Why?
| | Isoantibodies | 1 | 2009 | 52 | 0.080 |
Why?
| | Cleft Palate | 1 | 2009 | 45 | 0.080 |
Why?
| | Face | 1 | 2009 | 167 | 0.070 |
Why?
| | Models, Animal | 1 | 2009 | 350 | 0.070 |
Why?
| | Fascia | 1 | 2023 | 14 | 0.060 |
Why?
| | Atrophy | 1 | 2023 | 152 | 0.050 |
Why?
| | Abatacept | 1 | 2022 | 40 | 0.050 |
Why?
| | Neoplasms | 1 | 2016 | 2118 | 0.050 |
Why?
| | Optic Nerve | 1 | 2022 | 65 | 0.050 |
Why?
| | Rabbits | 1 | 2023 | 752 | 0.050 |
Why?
| | Sirolimus | 1 | 2022 | 192 | 0.050 |
Why?
| | Chromatography, Liquid | 1 | 2022 | 347 | 0.050 |
Why?
| | Transplantation, Heterotopic | 1 | 2020 | 16 | 0.050 |
Why?
| | Internship and Residency | 2 | 2020 | 951 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 251 | 0.040 |
Why?
| | Macaca | 1 | 2020 | 51 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2022 | 414 | 0.040 |
Why?
| | Schwann Cells | 1 | 2020 | 27 | 0.040 |
Why?
| | Maternal Health | 1 | 2019 | 44 | 0.040 |
Why?
| | Contrast Media | 1 | 2022 | 362 | 0.040 |
Why?
| | Delayed-Action Preparations | 1 | 2020 | 159 | 0.040 |
Why?
| | Tissue Engineering | 1 | 2023 | 366 | 0.040 |
Why?
| | Schools, Medical | 1 | 2020 | 123 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 546 | 0.040 |
Why?
| | GAP-43 Protein | 1 | 2018 | 5 | 0.040 |
Why?
| | Axons | 1 | 2020 | 179 | 0.040 |
Why?
| | Intermediate Filaments | 1 | 2018 | 46 | 0.040 |
Why?
| | Tensile Strength | 1 | 2018 | 103 | 0.040 |
Why?
| | Needs Assessment | 1 | 2019 | 318 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 2018 | 80 | 0.040 |
Why?
| | Elastomers | 1 | 2017 | 29 | 0.040 |
Why?
| | Polyesters | 1 | 2017 | 65 | 0.040 |
Why?
| | Faculty, Medical | 1 | 2020 | 234 | 0.040 |
Why?
| | Male | 7 | 2020 | 55949 | 0.030 |
Why?
| | Neovascularization, Physiologic | 1 | 2018 | 174 | 0.030 |
Why?
| | Hyaluronic Acid | 1 | 2018 | 190 | 0.030 |
Why?
| | Societies, Medical | 1 | 2020 | 684 | 0.030 |
Why?
| | Wound Healing | 1 | 2018 | 257 | 0.030 |
Why?
| | Collagen | 1 | 2018 | 415 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2023 | 9159 | 0.030 |
Why?
| | Cytokines | 1 | 2023 | 1853 | 0.030 |
Why?
| | Back | 1 | 2014 | 10 | 0.030 |
Why?
| | Tissue Expansion | 1 | 2014 | 11 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2017 | 301 | 0.030 |
Why?
| | Time Factors | 2 | 2019 | 6165 | 0.030 |
Why?
| | Child | 2 | 2014 | 18488 | 0.030 |
Why?
| | Biocompatible Materials | 1 | 2018 | 378 | 0.030 |
Why?
| | Fetus | 1 | 2018 | 702 | 0.030 |
Why?
| | United States | 2 | 2020 | 12295 | 0.030 |
Why?
| | Pulse Therapy, Drug | 1 | 2013 | 6 | 0.030 |
Why?
| | Neural Conduction | 1 | 2013 | 79 | 0.030 |
Why?
| | Sciatic Nerve | 1 | 2013 | 56 | 0.030 |
Why?
| | Gene Expression | 1 | 2018 | 1435 | 0.030 |
Why?
| | Muscular Atrophy | 1 | 2013 | 74 | 0.030 |
Why?
| | Locomotion | 1 | 2013 | 81 | 0.030 |
Why?
| | Attitude of Health Personnel | 1 | 2019 | 990 | 0.030 |
Why?
| | Dexamethasone | 1 | 2013 | 316 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2022 | 3069 | 0.020 |
Why?
| | Acute Disease | 1 | 2013 | 914 | 0.020 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2009 | 60 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2013 | 448 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 4435 | 0.020 |
Why?
| | Rats, Inbred WF | 1 | 2009 | 5 | 0.020 |
Why?
| | Antilymphocyte Serum | 1 | 2009 | 66 | 0.020 |
Why?
| | Femoral Vein | 1 | 2009 | 28 | 0.020 |
Why?
| | Administration, Topical | 1 | 2009 | 137 | 0.020 |
Why?
| | Anastomosis, Surgical | 1 | 2009 | 140 | 0.020 |
Why?
| | Female | 3 | 2020 | 59913 | 0.020 |
Why?
| | Pregnancy | 1 | 2019 | 5548 | 0.020 |
Why?
| | Biomarkers | 1 | 2018 | 3466 | 0.020 |
Why?
| | Femoral Artery | 1 | 2009 | 167 | 0.020 |
Why?
| | Risk Factors | 1 | 2019 | 8697 | 0.020 |
Why?
| | Adult | 2 | 2019 | 30718 | 0.020 |
Why?
| | Cohort Studies | 1 | 2014 | 4944 | 0.020 |
Why?
| | Skin | 1 | 2009 | 662 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2013 | 2161 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 10470 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2014 | 12608 | 0.010 |
Why?
| | Adolescent | 1 | 2014 | 17889 | 0.010 |
Why?
|
|
Washington's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|